Dr Reddy's CEO Erez Israeli says the pivot is already visible - India and Europe growth is now driven by innovation, consumer ...

Novartis "can never be done" when it comes to major acquisitions in its sector as it always needs to look for the next "great ...

Eli Lilly (LLY) stock has continued its gradual ascent this month, building on a year marked by steady performance. Investors ...

AstraZeneca (LSE:AZN) has delivered returns of 12% over the past month and 16% in the past 3 months, catching the attention ...

Decision is a setback for Dr. Reddy’s Laboratories, which was poised to be one of the first generic competitors to Ozempic ...

However, sentiment ahead of Q3 appears cautious—in the past three months, EPS estimates have seen 17 downward revisions ...

TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...

Spot shows folks running as a symbol of how the health-challenged can chase their dreams because of Sanofi meds.

While Novo Nordisk has been victimized by broader market pressure, NVO stock has just flashed a reliable quant signal for ...

Eli Lilly plans to acquire a gene therapy developer that once planned a 200-job facility in Research Triangle Park.

The New Jersey-based pharma giant has begun construction on a $3 billion, 400,000-square-foot manufacturing facility in ...

Johnson & Johnson’s medical technology unit and its health data company Verily have penned separate new deals with technology ...